Do biological immunomodulators improve the healing rate in surgically treated perianal Crohn 's fistulas?
There is a definite role for biological therapy as an adjuvant to surgery in patients with perianal fistulas and CD.
ACC continues to be a deadly disease, and little to no progress has been made from a treatment standpoint in the past 20 years. Careful and complete surgical resection is of the utmost importance. Although feasible in many cases and tempting, laparoscopic resection should not be attempted in patients with tumors suspicious for or known to be adrenocortical carcinoma.